Cynthia J. Helphingstine

Dr. Helphingstine joined BioCrossroads in 2006.
Prior to joining BioCrossroads, she was President and CEO of Tienta Sciences,Inc. and Vice President, Business Development for Inproteo, where she was responsible for commercializing technology resulting from Inproteo's research investments.
Prior to joining Inproteo and Tienta Sciences, Dr. Helphingstine was President of The Biotron Group, Inc., a consulting firm she founded to help healthcare and biotechnology companies understand and profit from changing markets and technologies.
Biotron provided such services as strategy development/ confirmation, technology and market assessment, due diligence and joint venture planning to start-up companies as well as members of the Fortune 100.
Before founding Biotron, Dr. Helphingstine spent nine years at Baxter Healthcare Corporation where she held management positions in product and business development, program management and clinical research.
Dr. Helphingstine holds a Ph.D.
in Immunology from the University of Missouri-Columbia and a BA in microbiology, also from UMC.
She also holds an MBA from the Lake Forest School of Management in Illinois.
She is currently a member of the Board and Chair of the Audit and Compensation Subcommittee for Monarch Life Sciences.